Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine for IOP in RALP
NCT02818816Phase 4Completed
- Sponsor
- University Health Network
- Start
- Feb 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine in ocular hypertension, sponsored by University Health Network. Started Feb 2016; status: completed.
02
Drugs
brimonidine
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on NCT02818816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02818816.